Loading...
Market
Story
$HIMS Adds GLP-1 Injections to Weight Loss Program, Stock Surges 38%
May 20, 2024, 01:51 PM
Hims & Hers Health ($HIMS) has announced the addition of compounded GLP-1 injections to its weight loss program, a move that has significantly boosted its stock price. The telehealth company aims to offer these weight-loss shots at a discount compared to name-brands like Ozempic and Wegovy. Following the announcement, Hims & Hers' stock surged by as much as 38% in trading today, with notable increases of 10%, 20%, and 30% at various points. This strategic expansion into weight loss treatments is expected to enhance the company's market position and attract more customers seeking affordable options.
View original story
Similar markets
Top 10% • 25%
Top 25% • 25%
Top 50% • 25%
Below 50% • 25%
Below 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
Above 30% • 25%
0-1 partnerships • 33%
2-3 partnerships • 33%
4 or more partnerships • 34%
No Partnership • 25%
1-3 Major Partnerships • 25%
4-6 Major Partnerships • 25%
7 or More Major Partnerships • 25%
None • 33%
1-2 new partnerships • 33%
More than 2 new partnerships • 33%
Below 50% satisfaction • 25%
50% to 70% satisfaction • 25%
70% to 90% satisfaction • 25%
Above 90% satisfaction • 25%
0-5 partnerships • 25%
6-10 partnerships • 25%
11-15 partnerships • 25%
More than 15 partnerships • 25%
Collaborations with universities • 25%
Collaborations with private research firms • 25%
Collaborations with international research institutes • 25%
No significant new collaborations • 25%